No Data
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
AI has gained recognition from pharmaceutical giants! Novo-Nordisk A/S: AI is finally reliable enough to generate sensitive documents.
Currently, Novo-Nordisk A/S has begun using Claude to draft clinical study reports, with each report potentially reaching hundreds of pages. Relevant authorities revealed that the use of AI tools has significantly shortened the drafting time from about 15 weeks to less than 10 minutes, and the company's annual expenditure on Claude is less than the salary of a single writer.
European stock markets closed higher, with gains in Medical Care stocks offsetting the decline in Technology stocks.
European stock markets rose on Tuesday, with gains in Medical Care and Banks stocks offsetting the decline in the Technology Sector and Unilever. The Stoxx Europe 600 Index closed up 0.2%, having earlier dropped by 0.3%. Novo-Nordisk A/S shares rose after Hims and HERS Health Inc. announced it would stop selling some weight loss drugs, pushing Medical Care stocks up by 1%. Xerox shares also climbed following better-than-expected performance. Concerns about the USA potentially imposing stricter restrictions on semiconductor companies weighed down the Technology stocks. STMicroelectronics shares were under pressure due to the Italian government's intention to replace this chip manufacturer.
Novo Nordisk Shares Rise as Hims & Hers to Stop Mimicking Weight-Loss Drugs
Novo Nordisk A/S (NVO): A High Growth Mega Cap Stock You Can Buy and Hold for the Next 5 Years
Lilly Cuts Price of Zepbound Vials to Battle Cheaper Copycats
Unlock the Full List
